chevron
is a collection of high-level functions to create standard outputs for clinical trials reporting with limited parameterisation. These outputs includes:
-
Tables:
- safety table, e.g.
- adverse events table, e.g.
- demographic table, e.g.
- ECG table, e.g.
- lab results table, e.g.
- medical history table, e.g.
- response table, e.g.
- time to event table, e.g.
- vital signs, e.g.
- Listings
- Graphs:
Please visit the catalog to see full list of available outputs. If you want a new output, please create an issue.
If you need more flexibility please refer to tern
with its TLG Catalog.
Installation
install.packages("chevron", repos = c("https://insightsengineering.r-universe.dev", getOption("repos")))
# install.packages("pak")
pak::pak("insightsengineering/chevron@*release")
Alternatively, you might also use the development version.
install.packages("chevron", repos = c("https://pharmaverse.r-universe.dev", getOption("repos")))
# install.packages("pak")
pak::pak("insightsengineering/chevron")
Usage
which returns
MedDRA System Organ Class A: Drug X B: Placebo C: Combination
MedDRA Preferred Term (N=134) (N=134) (N=132)
———————————————————————————————————————————————————————————————————————————————————————————————————————
Total number of patients with at least one adverse event 122 (91.0%) 123 (91.8%) 120 (90.9%)
Overall total number of events 609 622 703
cl A.1
Total number of patients with at least one adverse event 78 (58.2%) 75 (56.0%) 89 (67.4%)
Total number of events 132 130 160
dcd A.1.1.1.1 50 (37.3%) 45 (33.6%) 63 (47.7%)
dcd A.1.1.1.2 48 (35.8%) 48 (35.8%) 50 (37.9%)
cl B.2
Total number of patients with at least one adverse event 79 (59.0%) 74 (55.2%) 85 (64.4%)
Total number of events 129 138 143
dcd B.2.2.3.1 48 (35.8%) 54 (40.3%) 51 (38.6%)
dcd B.2.1.2.1 49 (36.6%) 44 (32.8%) 52 (39.4%)
cl D.1
Total number of patients with at least one adverse event 79 (59.0%) 67 (50.0%) 80 (60.6%)
Total number of events 127 106 135
dcd D.1.1.1.1 50 (37.3%) 42 (31.3%) 51 (38.6%)
dcd D.1.1.4.2 48 (35.8%) 42 (31.3%) 50 (37.9%)
cl D.2
Total number of patients with at least one adverse event 47 (35.1%) 58 (43.3%) 57 (43.2%)
Total number of events 62 72 74
dcd D.2.1.5.3 47 (35.1%) 58 (43.3%) 57 (43.2%)
cl B.1
Total number of patients with at least one adverse event 47 (35.1%) 49 (36.6%) 43 (32.6%)
Total number of events 56 60 62
dcd B.1.1.1.1 47 (35.1%) 49 (36.6%) 43 (32.6%)
cl C.2
Total number of patients with at least one adverse event 35 (26.1%) 48 (35.8%) 55 (41.7%)
Total number of events 48 53 65
dcd C.2.1.2.1 35 (26.1%) 48 (35.8%) 55 (41.7%)
cl C.1
Total number of patients with at least one adverse event 43 (32.1%) 46 (34.3%) 43 (32.6%)
Total number of events 55 63 64
dcd C.1.1.1.3 43 (32.1%) 46 (34.3%) 43 (32.6%)